Centiva Capital’s Evolent Health EVH Stock Holding History

Centiva Capital’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-88,961	Closed	-$203K	–	1956
2026 Q1	$203K	Buy	88,961 +67,825	+321%	+$215K	﹤0.01%	1271
2025 Q4	$84.5K	Buy	+21,136	New	+$117K	﹤0.01%	1093
2024 Q3	–	Sell	-49,946	Closed	-$955K	–	2281
2024 Q2	$955K	Buy	49,946 +26,544	+113%	+$678K	0.02%	802
2024 Q1	$767K	Buy	23,402 +8,484	+57%	+$271K	0.02%	788
2023 Q4	$493K	Buy	+14,918	New	+$422K	0.01%	969
2022 Q3	–	Sell	-10,736	Closed	-$330K	–	1595
2022 Q2	$330K	Buy	+10,736	New	+$313K	0.01%	1093

Other funds holding EVH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Centiva Capital's EVH Position: Q2 2026 in Review

Centiva Capital sold out of Evolent Health (EVH) in Q2 2026, closing a stake of 88,961 shares — an estimated $203K sold.

Centiva Capital first reported a position in EVH in Q2 2022 and held it in 6 quarters. The position peaked at $955K in Q2 2024. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

Centiva Capital reported no remaining Evolent Health position as of Q2 2026 after selling out during the quarter.
Centiva Capital sold 88,961 Evolent Health shares in Q2 2026, an estimated $203K.
Centiva Capital first reported a position in Evolent Health in Q2 2022 and held it in 6 quarters.
Centiva Capital's Evolent Health position peaked at $955K in Q2 2024.
199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.